The mutations at Vps13d codon 295 and Tgfbr2 codon 549 were not observed in adenocarcinoma samples (8 of 8 examined, data not shown) obtained in an in vivo DMBA-treated experiment using BALB/c-Trp53 knockout female mice (Machida and Imai, 2021). Here, VPS13D is linked to adenocarcinoma.